चिन्ह | एक्सचेंज | करेंसी |
|---|
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase IIa clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial. It is also developing CANxx antibodies against IL1RAP. The company has collaboration agreements with Patheon Biologics BV and BioWa Inc. for the manufacture and production of CAN04; and Specialized Medical Services-oncology BV for the clinical study of CAN04. Cantargia AB (publ) was founded in 2010 and is based in Lund, Sweden.
प्रकार | 5 मिनट | 15 मिनट | प्रति घंटा | दैनिक | मासिक |
|---|---|---|---|---|---|
| मूविंग एवरेज | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
| तकनीकी संकेतक | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
| सारांश | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
नाम | अंतिम | उच्च | निम्न | बदलाव | बदलाव % | वॉल्यूम | समय | ||
|---|---|---|---|---|---|---|---|---|---|
| 631.35 | 651.00 | 622.35 | +1.40 | +0.22% | 1.01M | NSE | |||
| 58.30 | 58.70 | 56.60 | +0.90 | +1.57% | 6.05K | NSE | |||
| 421.50 | 423.95 | 419.10 | +5.45 | +1.31% | 1.62M | NSE | |||
| 506.45 | 548.95 | 494.00 | +21.85 | +4.51% | 749.71K | NSE | |||
| 8,101.30 | 8,150.00 | 8,056.35 | +127.45 | +1.60% | 82.72K | NSE | |||
| 54.45 | 54.45 | 54.35 | +2.55 | +4.91% | 523.57K | BSE | |||
| 7.06 | 7.19 | 7.03 | -0.04 | -0.56% | 8.26K | BSE | |||
| 75.00 | 75.85 | 74.25 | +1.55 | +2.11% | 9.12K | NSE | |||
| 1,726.00 | 1,734.20 | 1,716.05 | +21.50 | +1.26% | 1.03M | NSE | |||
| 866.00 | 869.00 | 860.70 | +7.85 | +0.91% | 1.80M | NSE | |||
| 2,919.50 | 2,932.00 | 2,897.00 | +58.10 | +2.03% | 709.77K | NSE | |||
| 123.20 | 123.45 | 121.25 | +2.25 | +1.86% | 13.02M | NSE | |||
| 1.20 | 1.20 | 1.15 | +0.050 | +4.35% | 3.59M | NSE | |||
| 0.45 | 0.50 | 0.45 | 0.00 | 0.00% | 0.00 | NSE | |||
| 404.80 | 406.00 | 398.15 | +5.20 | +1.30% | 51.72K | NSE |